AusPAR: Keytruda | Therapeutic Goods Administration (TGA)

AusPAR

AusPAR: Keytruda [PDF, 791.79 KB]

AusPAR: Keytruda [Word, 1.92 MB]

Attachment-Product information for Keytruda [PDF, 1.39 MB]

Attachment-Product information for Keytruda [Word, 1.38 MB]

Device/Product Name

Keytruda

Active ingredients

Pembrolizumab

AusPAR Date

8 June 2023

Published

15 June 2023

Submission Number

PM-2020-01294-1-4

Submission Type

Extension of indications

Decision

Approved